Diabetic retinopathy screening in type 2 diabetics in a health area of ​​the metropolitan area
DOI:
https://doi.org/10.51481/amc.v44i2.408Keywords:
Diabetes mellitus tipo 2, retinopatía diabética, tamizaje, prevalenciaAbstract
Costa Rica has a population of 4 million and an estimatedprevalence ofDiabetes mellitus type 2 of 6% . T h i srepresents around 130,000 diabetic patients in the wholec o u n t r y. It is known that the chronic complications ofdiabetes have a great impact in the quality of life of thesepersons. Diabetic rethinopathy is one of the most important;if it is not diagnosed early and treatment, it can lead to lossof vision. The prevalence of this pathology and how well it isapproached by the Costa Rican Health System is unknown.The objective of this study is to find out how the Health Areaof Desamparados 3, an urban-marginal comunity of themetropolitan area, has coped with this complication up ton o w, and to determinewith aretinopathyscreeningintervention an estimate of its prevalence.The medical records of 572 diabetics where checked,searching for the results of eye fundoscopic examination inthe last two years. Those patients that had no previous eyeexaminationwere dilated and examined by experienceclinicians. Ninety three percent of the patients had had noeye test in the last two years, even worse, 89% had no eyeexamination intheir medical records at all. After thescreening intervention, a funduscopic exam was obtained in345 patients (60.3%). Of these, 27% had diabetic retinopathy;16.5% had basic non proliferative, 8.7% had severe nonproliferative and 2.3% had with proliferative retinopathy.Thirty patients had severe non proliferative retinopathy thatneeded fotocoagulation intervention on urgent basis. Threehad macular oedema that needed urgent treatment. Access tohospitals oftalmologic facilities for the studied area waslimited, having waiting lists up to three months.73Tamizaje de retinopatía diabética/ Laclé A et alThis study showed that diabetic retinopathy is not beingdiagnosed because ophtalmics funduscopic examination isnot being done, not only in primary care but also in patientsthat arecontroled athospital level.The screeningintervention was well accepted by the patients, but thereferral of these patients to the hospitals is not wellcoordinated.To achieve near universal coverage for patiets withs thiscomplication, the screening method has to be communitybased and the point of delivery within easy reach of thepopulation. Many different modalities of screening are inuse, depending on local availability of facilities. Costa Ricahas to seek the best way to achieve total coverage, and webelieve its has the capacity of doing so.
Downloads
References
Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD,Ferris FL 3rd, et al, Diabetic Retinopathy ( Technical Review).Diabetes Care 1998, 21:143-156.
Klein R., Klein B.E., Moss, S.E., Davis, M.D., and DeMets, D.L. TheWisconsinEpidemiologicStudy of DiabeticRetinopathy.III.Prevalence and risk of diabetic retinopathy when age at diagnosis is 30years or older. Arch. Ophthalmol, 1984,102: 527-532.
DiabetesControl andComplicationsTrialResearchGroup:Progression of retinopathywithintensiveversusconventionaltreatmente in the DCCT. Ophthalmology 1995, 102: 647-661.
.UK Prospective diabetes Study Group: Intensive blood-glucose controlwith sulphonylureas or insulin compared with conventional treamentand risk of complications in patients with type 2 diabetes (UKPDS 33 )Lancet 1998, 352:837-853
American Diabetes Asociation Working group. Implications of theUnited Kingdom Prospective Diabetes Study. Diabetes Care January2000 Suplement I :527-531.
Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S. etal, Intensive insulin therapy prevents the progression of diabeticmicrovascular complications in japanese patients with non-insulin-dependent diabetes: a randomized prospective 6- years study. DiabetesRes Clin Pract 1995, 28:103-117.
Morice A, Rosello M, Arauz AG, Sánchez G, Padilla G. Diabetesmellitus en Costa Rica: un análisisinterdisciplinario. Serie dedocumentos técnicos, INCIENSA, Tres Rios, Costa Rica,1999.
AmericanCollegeofPhysicians,AmericanAcademyofOphtalmology: Screening guidelines for diabetic retinopathy . Clinicalguideline, Ophthalmolgy 1992, 99:1626-1628.
Diabetic RetinopathyStudyResearchGroup:Indications forphotocoagulation treatment of diabetic retinopathy ( DRS Report No 14) Int Ophthalmol Clin 1987 27: :239-253.
Dandona L., Dandona R., Naduvilath TJ., McCarty CA. Rao GN.Population based assessment of diabetic retinopathy in an urbanpopulation in southern India British Journal of Ophthalmology. 1999,83(8):937-940.
Dowse GK, Humphrey AR, Collins VR, Plehwe W, Gareeboo H,Fareed D et al, Prevalence and Risk Factors for Diabetic Retinopathyin the Multiethnic Population of Mauritius., Am J Epidemiol1998;147:448-57.
Meng-Hee Tan , MacLean, David R The prevalence of diabeticretinopathy in southern Alberta, Canada Clin Invest Med 1995; 18 (4):240-246.
Stefaniotou M, Kitsos G, Paschides C, Kalogeropoulos Chr., AspiotisM, Gorgolis S, et al, The prevalence of Diabetic Retinopathy in type IIDiabetes Mellitus in Northwest Greece (Epirus) Greek Annals ofOphthalmology 1997, 1: 65-70.
Reenders K, de Nobel E, van den Hoogen H, van Weel C. Screening fordiabetic retinopathy by general practitioners. Scand J Prim Health Care1992 Dec;10(4):306-9.
Sullivan F.M. Stearn R and MacCuish A.C. The role of generalpractitioners in diabetic eye care in Lankarshire Diabetic Medicine1994,13(5) :583-585..
Taylor R. Practical community screening for diabetic retinopathy usingth mobile retinal camera : report of a 12 centre study. British DiabeticAssociation Mobile Retinal Screening Group. Diabetic Medicine 1996,13 (11) : 945-52.
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Médica Costarricense

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)



